HER2 POSITIVE BREAST CARCINOMA

Clinical trials for HER2 POSITIVE BREAST CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new HER2 POSITIVE BREAST CARCINOMA trials appear

Sign up with your email to follow new studies for HER2 POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet finished but already full! 9 Completed 1 Terminated 2

Three-drug combo tested to stop early breast cancer from coming back

Disease control Completed

This study tested a combination of three drugs given after surgery for early-stage HER2-positive breast cancer. The goal was to see if this treatment could help prevent the cancer from returning and to understand its side effects. It involved 20 patients who received the drug reg…

Matched conditions: HER2 POSITIVE BREAST CARCINOMA

Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

HER2 POSITIVE BREAST CARCINOMA

Get alerted when new HER2 POSITIVE BREAST CARCINOMA trials appear

Three-drug combo tested to stop early breast cancer from coming back